It is remarkable that production of IL-8, HGF and IL-3 by CD14+DP PAC appeared rather well retained in T2DM patients, while production by CD14+DN myeloid cells is strongly affected, in particular in DR patients. The gene discussed is CD14; the disease is type 2 diabetes mellitus.